Medytox Faces Botulinum Approval Cancellation Over Data Issues
But Korean Firm Pushes Back
Executive Summary
Leading South Korean botulinum toxin company Medytox is facing substantial business risk as its Meditoxin product is suspended amid test result manipulation investigations.